Abstract
LBA4 The efficacy and safety of TQ-B2450 alone/with anlotinib in previously treated advanced non-small cell lung cancer (NSCLC): A multicenter, randomized, double-blind, placebo-controlled clinical trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have